sharewise4h
Society for Clinical Research Sites (SCRS) und Fortrea gehen eine Partnerschaft zur Förderung der Zusammenarbeit in der klinischen Forschung ein
Fortrea sponsert die Arbeitsgruppe „Collaborate Forward“ der SCRS und fördert die Zusammenarbeit für effizientere klinische Studien DURHAM, North Carolina, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Die ...
sharewise6h
Palantir Technologies Inc. sell FalconUpsurge31
This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...
sharewise6h
EQS-Adhoc: Deutsche Beteiligungs AG: Deutsche Beteiligungs AG beschließt Aktienrückkaufprogramm im Volumen von bis zu 20 Mio. Euro
EQS-Adhoc: Deutsche Beteiligungs AG: Deutsche Beteiligungs AG beschließt Aktienrückkaufprogramm im Volumen von bis zu 20 Mio.
sharewise8h
3 Beauty Stocks Off to an Ugly Start—Can 1 Stage a Comeback?
However, retail and wholesale beauty stocks have been in a steady decline, with losses accelerating in 2025. Once a Wall Street favorite, Ulta Beauty Inc. (NASDAQ: ULTA) ended 2024 down 11.24% and ...
sharewise8h
Buybacks Galore: 3 Mega-Caps Just Approved Billions in Buybacks
Three mega-cap names recently announced billions in share repurchase authorizations. Mega-cap generally refers to stock with market capitalizations of $200 billion or more. Below, I’ll detail ...
sharewise8h
Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Health insurance giant Humana Inc. (NYSE: HUM) stock initially rose in reaction to its fourth quarter of 2024 earnings report ...
sharewise9h
3 Reasons Occidental Petroleum Will Gush Higher in 2025
Occidental’s (NYSE: OXY) stock price struggles are over. The market corrected to long-term lows, aligning with Warren ...
sharewise10h
EQS-Adhoc: Rubean AG beschließt Kapitalmaßnahme zur Wachstumsfinanzierung
Diese Seite verwendet Cookies. Für eine vollständige Nutzung von sharewise sind Cookies zwingend notwendig. Du stimmst der ...
sharewise12h
Eli Lilly and Stock: Strategic $2B Acquisition Targets Weight Loss Market
Eli Lilly and is strengthening its position in the lucrative weight management sector through a significant $2 billion acquisition of Versanis Bio. This strategic move centers on Bimagrumab, a ...
sharewise12h
Rio Tinto ADR Stock: Board Overhaul Amid Profit Challenges
Rio Tinto, the global mining giant, is preparing for a significant transformation of its leadership structure, with multiple high-ranking board members set to depart throughout 2025. This ...
sharewise12h
Alibaba Stock: AI Push Drives Share Price Near Peak
Alibaba's stock continues its impressive upward momentum, with shares climbing 0.2% to reach $127.21 on Wednesday, positioning the stock just 1.41% below its 52-week high of $129.01. This remarkable ...
sharewise12h
Biomarin Pharmaceutical Stock: Q4 Profits Soar, 2025 Outlook Strong
Biomarin Pharmaceutical has demonstrated remarkable financial performance in the fourth quarter, with net profits reaching $125 million, translating to earnings per share of $0.64—a substantial ...